www.globes.co.il

www.globes.co.il
Share

www.globes.co.il

 •  August 17

Israeli drug development company Mapi Pharma Ltd. has completed a $10 million financing round. The money was raised from aMoon Fund, an Israeli firm investing in innovative Israeli healthcare and life science ventures, founded by Marius Nacht and Dr. Yair Schindel. Based in Ness Ziona, Mapi Pharma develops high barrier-to-entry, high added-value...

www.globes.co.il

 •  April 13

Israeli drug developer Protalix Biotherapeutics Inc. (NYSE MKT:PLX; TASE: PLX) saw its share price plunge 15% on Wall Street yesterday, giving it a market cap of $137 million, after publishing phase II clinical trial results of alidornase alfa for the treatment of Cystic Fibrosis (CF). The treatment, it is hoped, would be more effective than its...

www.globes.co.il

 •  February 14

Rainbow Medical, which specializes in seed and incubator investments in medical device start-ups and developing breakthrough medical technologies, has raised $25 million from investors in China. Rainbow Medical has also opened a China office to promote strategic collaborations. Rainbow Medical co-founder and CEO Efi Cohen-Arazi said, “We opened the...

www.globes.co.il

 •  February 14

Britain's National Health Service (NHS) has invited Israeli life sciences companies to conduct clinical trials in the UK. The invitation was made as part of the burgeoning collaboration between Israel and Britain's life sciences industries through the UK-Israel Tech Hub at the British Embassy in Tel Aviv and UK Trade and Investment (UKTI). UK has...